BioPorto A/S (CPH:BIOPOR)
0.9980
+0.0110 (1.11%)
At close: Feb 12, 2026
BioPorto Market Cap
BioPorto has a market cap or net worth of 488.66 million as of February 12, 2026. Its market cap has decreased by -24.88% in one year.
Market Cap
488.66M
Enterprise Value
469.40M
Revenue
36.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 488.66M, an increase of 549.13%. That is a compound annual growth rate of 9.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 488.66M | -3.24% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.36T |
| Genmab | 115.90B |
| Coloplast | 110.11B |
| ALK-Abelló | 47.11B |
| ChemoMetec | 6.87B |
| Gubra | 6.42B |
| Pharma Equity Group | 134.42M |
| ViroGates | 122.06M |